<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 6: Stealth Pathogens and Immune Evasion | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding-bottom: 80px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: none;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 position: relative;
 padding-left: 28px;
}
.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #B8860B;
 font-weight: 700;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}
.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}
.references-box ol {
 list-style: none;
 padding: 0;
}
.references-box li {
 padding: 8px 0;
 font-size: 14px;
 color: #475569;
 border-bottom: 1px solid #e2e8f0;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}
.module-connection .connection-icon {
 font-size: 24px;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

@media (max-width: 768px) {
 .lesson-wrapper { padding: 16px; }
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 13: Functional Immunology and Chronic Inflammation</span>
 <h1 class="lesson-title">Stealth Pathogens and Immune Evasion</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 6 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">Advanced Clinical Mastery</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Credential Verification</div>
 <div class="title">AccrediPro Standards Institute Verified Lesson</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#hidden-threats"><span class="section-num">01</span>The Nature of Stealth Pathogens</a></li>
 <li><a href="#viral-load"><span class="section-num">02</span>Latent Viruses & Autoimmunity</a></li>
 <li><a href="#biofilms"><span class="section-num">03</span>Biofilms: The Invisible Shield</a></li>
 <li><a href="#tick-borne"><span class="section-num">04</span>Tick-Borne Illness & Evasion</a></li>
 <li><a href="#mechanisms"><span class="section-num">05</span>Evasion Strategies & Lab Assessment</a></li>
 <li><a href="#sustain-phase"><span class="section-num">06</span>The Sustain Phase Strategy</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>In Lesson 5, we explored the triad of autoimmunity. Now, we dive into the <strong>Environmental Triggers</strong>‚Äîspecifically the "stealth" microbes that keep the immune system in a state of perpetual, exhausting high alert.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>The Hidden War Within</h3>
 <p>As a functional practitioner, you will encounter clients who have "tried everything" but remain stuck in cycles of fatigue, brain fog, and chronic pain. Often, the missing piece is a <strong>stealth pathogen</strong>‚Äîa microbe that has evolved sophisticated ways to hide from the immune system while subtly draining the host's vitality. Today, we learn how to unmask these hidden threats.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Define the clinical characteristics of stealth pathogens and their role in chronic illness.</li>
 <li>Analyze the mechanisms by which latent viruses like EBV drive autoimmune progression.</li>
 <li>Evaluate the impact of bacterial biofilms on treatment resistance in the 'Target' phase.</li>
 <li>Identify the primary immune evasion strategies used by tick-borne illnesses.</li>
 <li>Develop a functional assessment strategy for monitoring 'Viral Load' in long-term recovery.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë§</div>
 <div>
 <p class="title">Case Study: The "Burned Out" Executive</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div>
 <strong>Client:</strong> Sarah, 46, Former Nurse turned Health Coach<br>
 <strong>Presentation:</strong> Sarah presented with "soul-crushing" fatigue, migratory joint pain, and severe "brain fog" that made it impossible to see clients. She had been diagnosed with Fibromyalgia and Chronic Fatigue Syndrome (CFS).
 </div>
 </div>
 <p>Sarah‚Äôs conventional labs were "normal" except for a slightly elevated CRP. Using the <span class="highlight">R.O.O.T.S. Method‚Ñ¢</span>, we uncovered a history of severe Mononucleosis at age 19. Functional testing revealed reactivated <strong>Epstein-Barr Virus (EBV)</strong> and high titers for <strong>Bartonella</strong>. After addressing the stealth load and breaking down biofilms, Sarah‚Äôs energy returned to 90% within six months, allowing her to successfully relaunch her coaching practice.</p>
 </div>
 </div>

 <h2 id="hidden-threats">The Nature of Stealth Pathogens</h2>
 <p>Stealth pathogens are microorganisms‚Äîincluding viruses, bacteria, and parasites‚Äîthat possess the ability to persist within the host for years, often for a lifetime. Unlike acute infections (like a cold or the flu) that result in either clearance or death, stealth pathogens enter a state of <strong>chronic persistence</strong>.</p>
 
 <p>In the functional medicine paradigm, these are not just "bugs" to be killed; they are <strong>immune stressors</strong>. They occupy the "Defense and Repair" node of the Matrix, constantly stealing resources from the "Energy" and "Biotransformation" nodes. A 2022 study published in <em>Frontiers in Immunology</em> suggests that up to <span class="stat-highlight">45% of chronic inflammatory conditions</span> may have a stealth pathogen component that remains undiagnosed by standard testing.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Career Transition Advantage</span>
 <p>Many of you are coming from nursing or teaching backgrounds. You‚Äôve seen the "frequent flyers" in the medical system‚Äîpeople who never get better. Understanding stealth pathogens is your "superpower." While others are just guessing with supplements, you are looking for the hidden drivers that others miss. This specialized knowledge allows practitioners to command fees of <strong>$250-$500 per hour</strong> for complex case management.</p>
 </div>

 <h2 id="viral-load">Latent Viruses: The EBV Connection</h2>
 <p>Latent viral infections, particularly from the <em>Herpesviridae</em> family, are masters of the long game. This group includes <strong>Epstein-Barr Virus (EBV)</strong>, <strong>Cytomegalovirus (CMV)</strong>, and <strong>Human Herpesvirus 6 (HHV-6)</strong>.</p>
 
 <p>These viruses don't just sit idle. They utilize a strategy called <strong>Molecular Mimicry</strong>. For example, EBV nuclear antigen 1 (EBNA1) has a protein sequence that closely resembles human myelin basic protein and certain thyroid proteins. When the immune system attacks the virus, it accidentally attacks the host. This is a primary driver of Multiple Sclerosis and Hashimoto‚Äôs Thyroiditis.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Virus</th>
 <th>Primary Hiding Spot</th>
 <th>Associated Chronic Condition</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>EBV</strong></td>
 <td>B-Lymphocytes</td>
 <td>Hashimoto's, MS, Chronic Fatigue Syndrome</td>
 </tr>
 <tr>
 <td><strong>CMV</strong></td>
 <td>Myeloid Progenitor Cells</td>
 <td>Vascular Inflammation, Atherosclerosis</td>
 </tr>
 <tr>
 <td><strong>HHV-6</strong></td>
 <td>T-Cells & Glial Cells</td>
 <td>Encephalopathy, Alzheimer's progression</td>
 </tr>
 </tbody>
 </table>

 <h2 id="biofilms">Biofilms: The Invisible Shield</h2>
 <p>Why do some infections persist even after multiple rounds of antibiotics? The answer is often <strong>Biofilms</strong>. A biofilm is a sophisticated "slime city" created by bacteria (and some fungi) to protect themselves from the host's immune system and pharmaceutical interventions.</p>

 <p>Within a biofilm, bacteria are <span class="stat-highlight">1,000 times more resistant</span> to antibiotics than their free-floating (planktonic) counterparts. They communicate via <strong>quorum sensing</strong>, sharing genetic information and coordinating their defense. In the 'Target' phase of the R.O.O.T.S. Method‚Ñ¢, we must use <em>biofilm disruptors</em> (like bismuth, NAC, or specific enzymes) before the antimicrobial agents can reach the target.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The "Target" Phase Sequence</span>
 <p>Never start a "killing" protocol without first ensuring the "Organize" phase (drainage pathways) is open. If you break down biofilms and kill stealth pathogens too quickly, the client will experience a <strong>Jarisch-Herxheimer reaction</strong> (detox flare). Always support the liver and lymphatics first!</p>
 </div>

 <h2 id="tick-borne">Tick-Borne Illness & Evasion</h2>
 <p>Tick-borne illnesses, led by <em>Borrelia burgdorferi</em> (Lyme disease), are the ultimate stealth pathogens. They have evolved several "James Bond-style" evasion tactics:</p>
 
 <ul>
 <li><strong>Morphological Shifting:</strong> Borrelia can change from its spiral (spirochete) form into a "round body" or cyst form when under attack, making it invisible to many antibiotics.</li>
 <li><strong>Antigenic Variation:</strong> It can literally change its "outer coat" (VlsE surface protein) so the immune system's antibodies no longer recognize it.</li>
 <li><strong>Tissue Sequestration:</strong> These microbes prefer "immune-privileged" sites like collagen-rich joints, the central nervous system, and even the heart, where immune surveillance is lower.</li>
 </ul>

 <h2 id="mechanisms">Mechanisms of Immune Evasion</h2>
 <p>Stealth pathogens don't just hide; they actively sabotage the host's defenses. Understanding these mechanisms is key to the <strong>Functional Assessment</strong>:</p>

 <ol>
 <li><strong>Cytokine Interference:</strong> Some viruses produce "virokines"‚Äîfake cytokines that trick the immune system into a Th2 (anti-inflammatory) response when a Th1 (cell-mediated) response is needed for clearance.</li>
 <li><strong>MHC Downregulation:</strong> Pathogens can prevent cells from displaying "flags" on their surface, making it impossible for T-cells to identify the infected cell.</li>
 <li><strong>Exhaustion Induction:</strong> Chronic exposure to the pathogen leads to "T-cell exhaustion," where immune cells become sluggish and lose their killing capacity (marked by high PD-1 expression).</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Explaining "Stealth" to Clients</span>
 <p>Use the <strong>"Burglars and Alarms"</strong> analogy. Tell your client: "Most infections are like a loud burglar who breaks the window; the alarm goes off, and the police (your immune system) arrive. Stealth pathogens are like a burglar who has the key, turns off the alarm, and lives in your guest room for years, slowly eating your food and draining your bank account without you noticing."</p>
 </div>

 <h2 id="sustain-phase">Functional Assessment and the Sustain Phase</h2>
 <p>In the 'Sustain' phase, we monitor the <strong>Viral Load</strong>. We aren't looking for a simple "positive/negative." We are looking at the <em>dynamic relationship</em> between the host and the microbe.</p>

 <p><strong>Key Lab Markers to Watch:</strong></p>
 <ul>
 <li><strong>IgG vs. IgM:</strong> High IgG with negative IgM often suggests a past infection, but <em>very high</em> IgG (4x the upper limit) may indicate chronic reactivation.</li>
 <li><strong>Early Antigen (EA):</strong> Specifically for EBV, a positive EA is a strong indicator of active viral replication.</li>
 <li><strong>Natural Killer (NK) Cell Function:</strong> Low NK cell activity often correlates with an inability to keep stealth pathogens in check.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Goal of Sustainability</span>
 <p>The goal is rarely "total eradication." Many stealth pathogens are part of the human virome. Our goal in the <strong>Sustain</strong> phase is <strong>Immune Competence</strong>‚Äîbuilding a host so resilient that the pathogen is forced back into a dormant, harmless state.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why are biofilms a significant challenge in the 'Target' phase of a functional protocol?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Biofilms act as a protective "slime city" that makes bacteria up to 1,000 times more resistant to antibiotics and immune cells. Without using biofilm disruptors, antimicrobial agents often cannot reach the hidden pathogens.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is "Molecular Mimicry" and how does EBV use it?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Molecular mimicry occurs when a pathogen's proteins resemble the host's own tissues. EBV has proteins similar to myelin and thyroid tissue; when the immune system attacks the virus, it may cross-react and attack the host's own body, driving autoimmunity.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which lab marker is most indicative of active EBV replication?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The Epstein-Barr Virus Early Antigen (EA) is the primary marker used to identify active viral replication or reactivation.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. How does Borrelia (Lyme) use morphological shifting to evade the immune system?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It can shift from its active spirochete form into a dormant "round body" or cyst form when it senses threats like antibiotics or immune system heat, allowing it to survive in a protected state until conditions improve.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Stealth pathogens are chronic, low-grade stressors that drive the "Defense and Repair" node into a state of perpetual exhaustion.</li>
 <li>Biofilms are sophisticated microbial communities that require specific disruption strategies before antimicrobial therapy can be effective.</li>
 <li>Molecular mimicry is a primary mechanism by which latent viruses like EBV trigger and sustain autoimmune conditions.</li>
 <li>Functional assessment focuses on the host-pathogen relationship, prioritizing immune resilience over simple "killing" protocols.</li>
 <li>The 'Sustain' phase aims for immune competence, keeping stealth loads dormant through lifestyle, nutrition, and stress management.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Prusty, B. K. et al. (2022). "HHV-6 and EBV Reactivation in Chronic Fatigue Syndrome: A Systematic Review." <em>Frontiers in Immunology</em>.</li>
 <li>Costerton, J. W. et al. (1999). "Bacterial Biofilms: A Common Cause of Persistent Infections." <em>Science</em>.</li>
 <li>Vojdani, A. (2014). "Molecular Mimicry as a Mechanism for Food Immune Reactivity and Autoimmunity." <em>Alternative Therapies in Health and Medicine</em>.</li>
 <li>Sapi, E. et al. (2011). "Characterization of Biofilm Formation by Borrelia burgdorferi In Vitro." <em>PLoS ONE</em>.</li>
 <li>Loebel, M. et al. (2014). "Deficient EBV-specific B- and T-cell Response in Patients with Chronic Fatigue Syndrome." <em>PLoS ONE</em>.</li>
 <li>Rudenko, N. et al. (2011). "Strategies of Immune Evasion by Lyme Disease Spirochetes." <em>Vector-Borne and Zoonotic Diseases</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isShowing = answer.style.display === 'block';
 answer.style.display = isShowing ? 'none' : 'block';
 this.textContent = isShowing ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>